| Catalog No. | CS870016 |
|---|
| Species reactivity | Dog |
|---|
| Applications | Research Grade Biosimilar |
|---|
| Host species | Caninized |
|---|
| Isotype | IgG2-kappa |
|---|
| Expression system | Mammalian Cells |
|---|
| Clonality | Monoclonal |
|---|
| Target | CD279/PDCD1/PD1 |
|---|
| Concentration | 1.04mg/ml |
|---|
| Endotoxin level | Please contact the lab for this information. |
|---|
| Purity | >95% purity as determined by SDS-PAGE. |
|---|
| Purification | Protein A/G, purified from cell culture supernatant. |
|---|
| Accession | E2RPS2 |
|---|
| Form | Liquid |
|---|
| Storage buffer | 0.01M PBS,pH7.4. |
|---|
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -1358°C. |
|---|
| Alternate Names | AH-PD1,CAS:1808081-43-7 |
|---|
| Background | Gilvetmab is a potent caninized anti-PD-1 monoclonal antibody. gilvetmab blocks the interaction between PD-1 and its ligand PDL-1. |
|---|
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|---|
